Format

Send to

Choose Destination
Can J Physiol Pharmacol. 2018 Apr;96(4):412-418. doi: 10.1139/cjpp-2017-0559. Epub 2018 Jan 29.

Beneficial effects of N-acetylcysteine on hepatic oxidative stress in streptozotocin-induced diabetic rats.

Author information

1
Department of Chemistry and Biochemistry, São Paulo State University (UNESP), Institute of Biosciences, Botucatu, Brazil 18618-970.

Abstract

Diabetes is one of the leading diseases worldwide and, thus, finding new therapeutic alternatives is essential. The development of non-alcoholic fatty liver disease is a notable diabetic complication. Therefore, antioxidant therapy became a leading topic in the world of diabetes research. The objective of this present study was to evaluate the effects of antioxidant N-acetylcysteine (NAC) administration on serum biochemical parameters and oxidative stress parameters in hepatic tissue of the diabetic rats. Thirty-two animals were divided in 4 groups (n = 8): G1, normal rats; G2, normal rats + NAC; G3, diabetic rats; and G4, diabetic rats + NAC. Diabetes was induced in diabetic groups through streptozotocin. NAC administration was effective in improving hyperglycemia and hypoinsulinemia, as well as reducing serum alanine-aminotransferase and urea, hepatic triglycerides accumulation, and oxidative stress biomarkers in the diabetic liver, as well as improving the activity of hepatic antioxidant enzymes. This effect was likely due to NAC's ability of restoring intracellular glutathione, an important compound for the antioxidant defense, as well as due to NAC's direct antioxidant properties. Thus, NAC administration was useful for reducing hepatic oxidative stress and decreased the deposit of triacylglycerols, minimizing diabetic hepatic damage, making it a promising therapeutic adjuvant in the future.

KEYWORDS:

N-acetylcysteine; N-acétylcystéine; antioxidant; antioxydant; diabetes; diabète; dommages hépatiques; hepatic damage; non-alcoholic fatty liver disease; oxidative stress; streptozotocin; streptozotocine; stress oxydatif; stéatose hépatique non alcoolique

PMID:
29378152
DOI:
10.1139/cjpp-2017-0559
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center